Anemia and Acute Coronary Syndromes: Epidemiology, Etiology, Prognostic Value and Treatment
Anemia is an important negative predictor of short- and long-term risk in patients with acute (ACS) and chronic forms of coronary heart disease, especially in cases of manifest chronic heart failure (CHF), and is also an important perioperative risk predictor: it increases all causes mortality, and is associated with increased non-cardiac mortality. In addition, anemia is an independent risk factor of bleeding, while therapeutic options for the treatment of anemia remain limited. The aim of this study was evaluation of the incidence of anemia in patients with coronary artery disease who underwent myocardial revascularization and the impact of anemia on the risk of hemorrhagic events in the long-term prognosis. Our analyses showed that the incidence of anemia in patients with coronary artery disease who underwent myocardial revascularization upon discharge from the surgical hospital reaches 56.4 % (24.7 % in the ACS group and 96 % in the chronic Ischemic heart disease group). At the same time, only one of five patients is aware of the presence of anemia and only 1 % of anemic patients have the anemia treatment prescribtion at discharge. According to the literature analysis, anemia rises the risk of hemorrhagic events, therefore, special attention should be paid to its correction when examining patients with coronary heart disease, in order to prevent an increase in morbidity, select the correct therapy and prevent complications that may be associated with anemia.
Kalyuta T.Yu., Glushakova V.D., Glushakov I. A., Emelyanova I.P., Posnenkova O.M. 2022. Anemia And Acute Coronary Syndromes: Epidemiology, Etiology, Prognostic Value and Treatment. Challenges in Modern Medicine. 45 (4): 325–342 (in Russian). DOI: 10.52575/2687-0940-2022-45-4-325-342
While nobody left any comments to this publication.
You can be first.
Atabegashvili M.R., Konstantinova E.V., Kuzneczova V.A., Sharaeva Ya.V., Bogdanova A.A., Gilyarov M.Yu. 2019. Vy`bor blokatora P2Y12-receptorov dlya lecheniya pacienta s ostry`m koronarny`m sindromom: opy`t gorodskoj klinicheskoj bol`nicy № 1 im. N.I. Pirogova [The choice of a P2Y12-receptor blocker for the treatment of a patient with acute coronary syndrome: the experience of the city clinical hospital No. 1 named after N.I. Pirogov]. Medicinskij sovet. 5: 74–79. doi: https://doi.org/10.21518/2079-701X-2019-5-74-79.
Zhangelova Sh.B., Almuxambetova R.K., Zhangelova M.B., Kim A.V., Niyazbek Ya.B., Nurgalieva A.Zh. 2017. Ostry`j koronarny`j sindrom na fone anemii [Acute coronary syndrome associated with anemia]. Aktualnye problemy sovremennoj nauki. 26–29.
Kalyuta T.Yu., Kazhekin O.A., Ilyasova T.A., Kochenkova O.V. 2020. Prognosticheskoe znachenie anemicheskogo sindroma u planovy`x xirurgicheskix pacientov (obzor literatury`) [Prognostic significance of anemic syndrome in planned surgical patients (literature review)]. Aktual`ny`e problemy` mediciny.` 43 (1): 165–175.
Mansurova Zh.A., Karazhanova L.K. 2018. Nezavisimy`e prediktory` neblagopriyatny`x serdechnososudisty`x soby`tij u pacientov s ostry`m koronarny`m sindromom posle chreskozhnogo koronarnogo vmeshatel`stva vo vremya gospitalizacii [Independent predictors of adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention during hospitalization]. Kardiologiya. 58 (12): 22–29. doi: 10.18087/cardio.2018.12.10205.
Marcevich S.Yu., Zagrebel`ny`j A.V., Zolotareva N.P., Kutishenko N.P., Lukina Yu.V., Ginzburg M.L., Starcev D.A., Blagodatskix S.V. 2020. Registr ostrogo koronarnogo sindroma Lis-3: dinamika kliniko-demograficheskix xarakteristik i taktika do-gospital`nogo i gospital`nogo lecheniya vy`zhivshix pacientov, perenesshix ostry`j koronarny`j sindrom za 4-letnij period [Acute coronary syndrome register Lis-3: dynamics of clinical and demographic characteristics and tactics of prehospital and hospital treatment of surviving patients with acute coronary syndrome over a 4-year period]. RFK. 16 (2): 266–272. doi:10.20996/1819-6446-2020-04-15.
Al-Hijji M.A., Gulati R., Lennon R.J., Bell M., El Sabbagh A., Park J.Y., Slusser J., Sandhu G.S., Reeder G.S., Rihal C.S., Singh M. 2018. Outcomes of Percutaneous Coronary Interventions in Patients With Anemia Presenting With Acute Coronary Syndrome. Mayo. Clin. Proc. 93 (10): 1448–1461. doi: 10.1016/j.mayocp.2018.03.030.
Badimon L., Vilahur G., Rocca B., Patrono C. 2021. Cardiovasc Res. The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis. 17 (9): 2001–2015. doi: 10.1093/cvr/cvab003.
Breen K., Finnegan L., Vuckovic K., Fink A., Rosamond W., DeVon H.A. 2020. Multimorbidity in Patients With Acute Coronary Syndrome Is Associated With Greater Mortality, Higher Readmission Rates, and Increased Length of Stay: A Systematic Review. J. Cardiovasc. Nurs. 35 (6): E99-E110. doi: 10.1097/JCN.0000000000000748.
Cable C.A., Razavi S.A., Roback J.D., Murphy D.J. 2019. RBC Transfusion Strategies in the ICU: A Concise Review. Crit. Care. Med. Nov. 47 (11): 1637–1644. doi: 10.1097/CCM.0000000000003985
Ducrocq G., Gonzalez-Juanatey J.R., Puymirat E., Lemesle G., Cachanado M., Durand-Zaleski I., Arnaiz J.A., Martínez-Sellés M., Silvain J., Ariza-Solé A., Ferrari E., Calvo G., Danchin N., Avendaño-Solá C., Frenkiel J., Rousseau A., Vicaut E., Simon T., Steg P.G. 2021. REALITY Investigators. Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial. JAMA. 325 (6): 552–560. doi: 10.1001/jama.2021.0135.
Castini D., Persampieri S., Cazzaniga S., Ferrante G., Centola M., Lucreziotti S., Salerno-Uriarte D., Sponzilli C., Carugo S. 2017. Real-world clopidogrel utilization in acute coronary syndromes: patients selection and outcomes in a single-center experience. Ther. Adv. Cardiovasc. Dis. 11 (12): 323–331. doi: 10.1177/1753944717738911.
Chiwhane A., Burchundi S., Manakshe G., Kulkarni H. 2020. Incremental Prognostic Value of Anemia in Acute Coronary Syndrome from A Rural Hospital in India. Glob. Heart. 15 (1): 16. doi: 10.5334/gh.527.
Davidsen L., Kragholm K., Aldahl M., Polcwiartek C., Torp-Pedersen C. Soegaard P. 2020. Freeman P. Long-term impact of baseline anemia on clinical outcomes following percutaneous coronary intervention in stable angina. Open Heart. 7: e001319. doi: 10.1136/openhrt-2020-001319.
Coscia T., Nestelberger T., Boeddinghaus J., Lopez-Ayala P., Koechlin L., Miró Ò., Keller D.I., Strebel I., Yufera Sanchez A., Okamura B., Wussler D., Shrestha S., Hausknecht K., Martín-Sánchez F.J., Christ M., Kawecki D., Twerenbold R., Wildi K., Rubini Gimenez M., Mueller C. 2022. APACE Investigators. Characteristics and Outcomes of Type 2 Myocardial Infarction. JAMA Cardiol. 7 (4): 427–434. doi: 10.1001/jamacardio.2022.0043. PMID: 35262640; PMCID: PMC8908230.
Gimbel M.E., Tavenier A.H., Bor W., Hermanides R.S., de Vrey E., Heestermans T., Gin M.T.J, Waalewijn R., Hofma S., den Hartog F., Jukema W., von Birgelen C., Voskuil M., Kelder J., Deneer V., Ten Berg J.M. 2020. Ticagrelor Versus Clopidogrel in Older Patients with NSTE-ACS Using Oral Anticoagulation: A Sub-Analysis of the POPular Age Trial. J. Clin. Med. 9 (10): 3249. doi: 10.3390/jcm9103249.
Giustino G., Kirtane A.J., Baber U., Généreux P., Witzenbichler B., Neumann F.J., Weisz G., Maehara A., Rinaldi M.J., Metzger C., Henry T.D., Cox D.A., Duffy P.L., Mazzaferri E.L., Brodie B.R., Stuckey T.D., Gurbel P.A., Dangas G.D., Francese D.P., Ozan O., Mehran R., Stone G.W. 2016. Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study. Am. J. Cardiol. 117 (12): 1877–83. doi: 10.1016/j.amjcard.2016.03.034.
Guedeney P., Sorrentino S., Claessen B., Mehran R. 2019. The link between anemia and adverse outcomes in patients with acute coronary syndrome. Expert. Rev. Cardiovasc. Ther. 17 (3): 151–159. doi:10.1080/14779072.2019.1575729.
Guerrero C., Garay A., Ariza-Solé A., Formiga F., Raposeiras-Roubín S., Abu-Assi E., D'Ascenzo F., Kinnaird T., Manzano-Fernández S., Alegre O., Sánchez-Salado J.C., Lorente V., Templin C., Velicki L., Xanthopoulou I., Cerrato E., Rognoni A., Boccuzzi G., Omedè P., Montabone A., Taha S., Durante A., Gili S., Magnani G., Conrotto F., Bertaina M., Autelli M., Grosso A., Blanco P.F., Quadri G., Varbella F., Tomassini F., Queija B.C., Paz R.C., Fernández M.C., Pousa I.M., Gallo D., Morbiducci U., Dominguez-Rodriguez A., Valdés M., Alexopoulos D., Iñiguez-Romo A., Gaita F., Cequier Á. 2018. Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry. Thromb. Res.; 167: 142–148. doi:10.1016/j.thromres.2018.05.024.
Gonzalez-Juanatey J.R., Lemesle G., Puymirat E., Ducrocq G., Cachanado M., Arnaiz J.A., Martínez-Sellés M., Silvain J., Ariza-Solé A., Ferrari E., Calvo G., Danchin N., Avendano-Solá C., Rousseau A., Vicaut E., Gonzalez-Ferrero T., Steg P.G., Simon T. 2022. REALITY Investigators. One-Year Major Cardiovascular Events After Restrictive Versus Liberal Blood Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Trial. Circulation. 145 (6): 486–488. doi: 10.1161/CIRCULATIONAHA.121.057909. Epub 2022 Feb 7. PMID: 35130052.
Hosseini S.K., Ansari M.J., Lotfi M., Sharafi A., Kazazi E.A., Poorhosseini H. 2014. Association between preprocedural hemoglobin level and 1-year outcome of elective percutaneous coronary intervention. J. Cardiovasc. Med. 15: 331–335. doi:10.2459/JCM.0b013e32835ec938.
Huynh R., Hyun K., D'Souza M., Kangaharan N., Shetty P.C., Mariani J., Kilian J., Hung J., Ryan M., Chew D.P., Brieger D. 2019. Outcomes of anemic patients presenting with acute coronary syndrome: An analysis of the Cooperative National Registry of Acute Coronary Care, Guideline Adherence and Clinical Events. Clin. Cardiol. 42 (9): 791–6. doi:10.1002/clc. 23219.
Idris H., French J.K., Shugman I.M., Hopkins A.P., Juergens C.P., Thomas L. 2017. Influence of Age and Gender on Clinical Outcomes Following Percutaneous Coronary Intervention for Acute Coronary Syndromes. Heart. Lung. Circ. 26 (6): 554–565. doi: 10.1016/j.hlc.2016.10.021.
Jomaa W., Ben Ali I., Hamdi S., Azaiez M.A., Hraïech A.E., Ben Hamda K., Maatouk F. 2017. Prevalence and prognostic significance of anemia in patients presenting for ST-elevation myocardial infarction in a Tunisian center. J. Saudi. Heart. Assoc. 29 (3): 153–159. doi: 10.1016/j.jsha.2016.10.003.
Kwok C.S., Rao S.V., Myint P.K., Keavney B., Nolan J., Ludman P.F., de Belder M.A., Loke Y.K., Mamas M.A. 2014. Major bleeding after percutaneous coronary intervention and risk of subsequent mortality: a systematic review and meta-analysis. Open Heart. 1 (1): e000021. doi: 10.1136/openhrt-2013-000021.
Kwok C.S., Sherwood M.W., Watson S.M. Nasir S.B., Sperrin M., Nolan J., Kinnaird T., Kiatchoosakun S., Ludman P., A de Belder M., V Rao S., A Mamas M. 2015. Blood transfusion after percutaneous coronary intervention and risk of subsequent adverse outcomes: a systematic review and meta-analysis. JACC Cardiovasc. Interv. 8: 436–446. doi:10.1016/j.jcin.2014.09.026.
Lattuca B., Cayla G., Silvain J., Cuisset T., Leclercq F., Manzo-Silberman S., Saint-Etienne C., Delarche N., El Mahmoud R., Carrié D., Souteyrand G., Kerneis M., Hauguel-Moreau M., Zeitouni M., Guedeney P., Diallo A., Collet J.P., Vicaut E., Montalescot G. 2021. ACTION Study Group. Bleeding in the Elderly: Risk Factors and Impact on Clinical Outcomes After an Acute Coronary Syndrome, a Sub-study of the Randomized ANTARCTIC Trial. Am. J. Cardiovasc. Drugs. 21 (6): 681–691. doi:10.1007/s40256-021-00468-8.
Lee S.H., Jeong M.H., Han K.R., Sim D.S., Yoon J., Youn Y.J., Youn Y.J., Cho B.R., Cha K.S., Hyon M.S., Rha S.W., Kim B.O., Shin W.Y., Park K.S., Cheong S.S. 2016. Korean Transradial Coronary Intervention Registry Investigators. Comparison of Transradial and Transfemoral Approaches for Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome and Anemia. Am. J. Cardiol. 117 (10): 1582–1587. doi: 10.1016/j.amjcard.2016.02.030.
Martí D., Carballeira D., Morales M.J., Concepción R., Del Castillo H., Marschall A., Delgado-Calva FA, Dejuán-Bitriá C, Pérez-Guzmán J, López-Soberón E, Palazuelos J. 2020. Álvarez-Antón S. Impact of Anemia on the Risk of Bleeding Following Percutaneous Coronary Interventions in Patients ≥75 Years of Age. Am J Cardiol. 125 (8): 1142-1147. doi: 10.1016/j.amjcard.2020.01.010
Matsue Y., Matsumura A., Abe M., Ono M., Seya M., Nakamura T., Iwatsuka R., Mizukami A., Setoguchi M., Nagahori W., Ohno W., Suzuki M., Hashimoto Y. 2013. Prognostic implications of chronic kidney disease and anemia after percutaneous coronary intervention in acute myocardial infarction patients. Heart Vessels. 28: 19–26. doi:10.1007/s00380-011-0209-2.
Moghaddam N., Wong G.C., Cairns J.A., Goodman S.G., Perry-Arnesen M., Tocher W., Mackay M., Singer J., Lee T., Rao S.V., Fordyce C.B. 2018. Association of Anemia With Outcomes Among ST-Segment-Elevation Myocardial Infarction Patients Receiving Primary Percutaneous Coronary Intervention. Circ. Cardiovasc. Interv. 11 (12): e007175. doi:10.1161/CIRCINTERVENTIONS.118.007175.
Morici N., Cantoni S., Soriano F., Viola G., De Stefano V., Veas N., Oreglia J.A., Esposito G., Sacco A., Savonitto S. 2019. Alterazioni dell’emocromo nella sindrome coronarica acuta: ematologi e cardiologi a confronto [Relevance of complete blood count parameters in the assessment of acute coronary syndromes: a combined hematological and cardiological perspective]. G. Ital. Cardiol. (Rome). 20 (12): 694–705. Italian. doi: 10.1714/3271.32379.
Nagao K., Watanabe H., Morimoto T., Inada T., Hayashi F., Nakagawa Y., Furukawa Y., Kadota K., Akasaka T., Natsuaki S., Kozuma K., Tanabe K., Morino Y., Shiomi H., Kimura T. 2019. CREDO Kyoto PCI/CABG Registry Cohort 2, RESET, and NEXT Investigators. Prognostic Impact of Baseline Hemoglobin Levels on Long Term Thrombotic and Bleeding Events After Percutaneous Coronary Interventions. JAHA.; 8:e 013703 https://doi.org/10.1161/JAHA.119.013703.
Newhall D.A., Oliver R., Lugthart S. 2020. Anaemia: A disease or symptom. Neth. J. Med. 78 (3): 104–110. PMID: 32332184. https://pubmed.ncbi.nlm.nih.gov/32332184/
Neumann F.J., Sousa-Uva M., Ahlsson A., Alfonso F., Banning A.P., Benedetto U., Byrne R.A., Collet J.P., Falk V., Head S.J., Jüni P., Kastrati A., Koller A., Kristensen S.D., Niebauer J., Richter D.J., Seferovic P.M., Sibbing D., Stefanini G.G., Windecker S., Yadav R., Zembala M.O. 2019. ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart. J. 40 (2): 87–165. doi: 10.1093/eurheartj/ehy394. Erratum in: Eur Heart J. 40 (37): 3096.
Ntima G., Bepouka B., Tixier V., Ferrier N., Marcaggi X. 2018. Anémie chez les patients avec syndrome coronarien aigu au centre hospitalier de Vichy [Anemia in patients with acute coronary syndrome in the Vichy Hospital center]. Ann Cardiol Angeiol (Paris). 67 (5): 321–326. French. doi: 10.1016/j.ancard.2018.09.001.
Ohana-Sarna-Cahan L., Atar S. 2018. Clinical outcomes of patients with acute coronary syndrome and moderate or severe chronic anaemia undergoing coronary angiography or intervention. Eur. Heart. J. Acute. Cardiovasc. Care. 7 (7): 646–651. doi: 10.1177/2048872617707959.
Rao S.V., McCoy L.A., Spertus J.A., Krone R., Singh M., Fitzgerald S., Peterson E. 2013. An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry Cath PCI Registry. JACC Cardiovasc. Interv. 6: 897–904. doi:10.1016/j.jcin.2013.04.016.
Stucchi M., Cantoni S., Piccinelli E., Savonitto S., Morici N. 2018. Anemia and acute coronary syndrome: current perspectives. Vasc. Health. Risk. Manag. 14: 109–118. doi: 10.2147/VHRM.S140951
Vicente-Ibarra N., Marín F., Pernías-Escrig V., Sandín-Rollán M., Núñez-Martínez L., Lozano T., Macías-Villaniego M.J., Carrillo-Alemán L., Candela-Sánchez E., Guzmán E., Esteve-Pastor M.A., Orenes-Piñero E., Valdés M., Rivera-Caravaca J.M., Ruiz-Nodar J.M. 2019. Impact of anemia as risk factor for major bleeding and mortality in patients with acute coronary syndrome. Eur. J. Intern. Med. 61: 48–53. doi: 10.1016/j.ejim.2018.12.004.